Freenome
Freenome is an early cancer detection company founded in 2014 that develops blood-based screening tests to catch cancer in its earliest, most treatable stages. It combines multiomics laboratory science with artificial intelligence and machine learning to read multiple biological signals from a single blood draw, an approach it calls Personalized Cancer Detection. Its SimpleScreen portfolio includes tests for colorectal and lung cancer, validated through clinical research programs such as the PREEMPT CRC study. Freenome is a clinical diagnostics and life-sciences company; it does not currently publish a public developer API, SDK, or partner integration surface. This profile was added to the API Evangelist network as a venture-portfolio lead (backed by a16z, CRV, DCVC, and GV) and enriched with the public identity, legal, and domain-security signals available from its website.
Freenome is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Cancer Detection, Diagnostics, and Life Sciences.
Freenome’s developer surface includes engineering blog, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API